hC Bioscience, Inc. — Form D
hC Bioscience, Inc. of Cambridge, MA, a company, filed a Form D exempt-offering notice with the SEC on 2021-12-17. The offering totals $24.0M, of which $12.0M was reported sold. Industry: Other.
Offering
- Filed: 2021-12-17
- Form: D
- Accession: 0001898412-21-000001
- Industry: Other
- Exemptions: 06b
- Total offering: $24.0M
- Amount sold: $12.0M
- Remaining: $12.0M
- Investors: 4
- Date of first sale: 2021-12-03
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-425515
Issuer
- Name: hC Bioscience, Inc.
- CIK: 0001898412
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: One Broadway, 14th Floor, Cambridge, MA, 02142
- Phone: 617-515-6755
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| Christopher J Ahern | Executive Officer | Boston, MA |
| Brad J Margus | Director | Cambridge, MA |
| Leslie J Williams | Director | Cambridge, MA |
| Leslie J Williams | Executive Officer | Cambridge, MA |
| Benjamin J Chen | Director | Cambridge, MA |
| Seiji J Miyahara | Director | Cambridge, MA |
| Sacha J Mann | Director | Cambridge, MA |
| David J Moskowitz | Director | Cambridge, MA |
| Steven J Gillis | Director | Cambridge, MA |
Other filings by this issuer (1)
More